PMD102 - COST-EFFECTIVENESS OF USING [18F]FLUTEMETAMOL IN THE CLINICAL EVALUATION OF PATIENTS WITH MILD COGNITIVE IMPAIRMENT OR SUSPECTED DEMENTIA IN SPAIN